Literature DB >> 3524827

Abbreviated phase I clinical trial of i.v. mitozolomide.

R A Joss, H J Ryssel, A K Bischoff, A Goldhirsch, K W Brunner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3524827

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Relationship between the pharmacokinetics and toxicity of mitozolomide.

Authors:  D J Kerr; J A Slack; P Secrett; M F Stevens; G R Blackledge; C Bradley; S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Phase I study of mitozolomide on a once daily for 5 days schedule.

Authors:  J H Schornagel; G Simonetti; R Dubbelman; W W ten Bokkel Huinink; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  A clinical and pharmacological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue.

Authors:  M McKeage; P Dady; M Clear; A MacDonald
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.